Finance

Beta
Lists
AUPH:NASDAQ
Aurinia Pharmaceuticals Inc
$16.95
-3.42%
(-0.60) 1D
Jun 26, 3:44:40 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUPH...
Open
$17.53
High
$17.72
Low
$16.75
Mkt. cap
2.18B
Avg. vol.
1.42M
Volume
1.30M
P/E ratio
7.82
52-wk high
$19.25
52-wk low
$7.28
EPS
$2.17
Beta
1.41
Shares outstanding
128.60M
No. of employees
128
Open
$17.53
High
$17.72
Low
$16.75
Mkt. cap
2.18B
Avg. vol.
1.42M
Volume
1.30M
P/E ratio
7.82
52-wk high
$19.25
52-wk low
$7.28
EPS
$2.17
Beta
1.41
Shares outstanding
128.60M
No. of employees
128
News stories
From sources across the web
About Aurinia Pharmaceuticals Inc
CEO-
Employees128
Founded2012
Headquarters-
SectorBiotechnology
Websiteauriniapharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to AUPH in the past 3 months
Buy
Buy
1
Hold
2
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AUPH in the last 3 months.
Highest
Current $16.95
$17.00 (+0.29%)
Average
$15.67 (-7.55%)
Lowest
$15.00 (-11.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Martin PhD
Bloom Burton
Hold
Maintained
$15.00
-11.5%
05/11/2026
Douglas Miehm
RBC Capital
Hold
Reiterated
$15.00
-11.5%
05/08/2026
Stacy Ku
TD Cowen
Buy
Maintained
$17.00
+0.3%
05/07/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
$17.00
+0.3%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
70.01M
73.47M
77.11M
77.70M
Cost of goods sold
14.55M
8.50M
40.55M
13.98M
Cost of revenue
14.55M
8.50M
40.55M
13.98M
Research and development expenses
-
8.11M
-20.86M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.02M
26.18M
29.26M
22.03M
Operating expense
35.26M
35.22M
-6.37M
22.31M
Total operating expenses
49.81M
43.72M
34.18M
36.28M
Operating income
20.20M
29.74M
42.94M
41.42M
Other non operating income
-
-
-
-
EBT including unusual items
22.16M
31.96M
35.69M
43.92M
EBT excluding unusual items
22.27M
31.96M
35.69M
43.92M
Income tax expense
643.00K
411.00K
-175.10M
9.57M
Effective tax rate
2.90%
1.29%
-490.62%
21.79%
Other operating expenses
9.25M
929.00K
-14.77M
279.00K
Net income
21.51M
31.55M
210.79M
34.36M
Net profit margin
30.73%
42.95%
273.35%
44.21%
Earnings per share
0.16
0.23
1.53
0.25
Interest and investment income
3.19M
3.32M
3.50M
3.52M
Interest expense
-1.12M
-1.10M
-1.05M
-1.01M
Net interest expenses
2.07M
2.22M
2.45M
2.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
25.06M
34.61M
47.80M
46.24M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of AUPH
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer